SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2obv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EKJ_F_ACTF3008_0 (BETA-CARBONIC ANHYDRASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 8	PHE A 282 ASP A 291 GLY A 279 GLY A 278	None	0.90A	1ekjE-2obvA: undetectable 1ekjF-2obvA: undetectable	1ekjE-2obvA: 19.95 1ekjF-2obvA: 19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FB7_A_ROCA100_1 (HIV-1 PROTEASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 12	GLY A 260 ASP A 35 GLY A 28 THR A 86 VAL A 83	None	0.94A	1fb7A-2obvA: undetectable	1fb7A-2obvA: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OHR_A_1UNA201_1 (ASPARTYLPROTEASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	6 / 11	ASP A 31 ASP A 35 GLY A 28 THR A 86 VAL A 83 ILE A 37	None	1.24A	1ohrA-2obvA: undetectable	1ohrA-2obvA: 15.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.31A	1p7lC-2obvA: 57.3	1p7lC-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.42A	1p7lD-2obvA: 57.2	1p7lD-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.43A	1p7lC-2obvA: 57.3	1p7lC-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.30A	1p7lD-2obvA: 57.2	1p7lD-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.30A	1rg9A-2obvA: 57.4	1rg9A-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.44A	1rg9B-2obvA: 57.4	1rg9B-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.42A	1rg9A-2obvA: 57.4	1rg9A-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.30A	1rg9B-2obvA: 57.4	1rg9B-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.33A	1rg9C-2obvA: 57.3	1rg9C-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.41A	1rg9D-2obvA: 57.3	1rg9D-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.42A	1rg9C-2obvA: 57.3	1rg9C-2obvA: 56.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.32A	1rg9D-2obvA: 57.3	1rg9D-2obvA: 56.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NNP_A_ROCA401_1 (PROTEASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 11	GLY A 260 ASP A 35 GLY A 28 THR A 86 VAL A 83	None	0.94A	2nnpA-2obvA: undetectable	2nnpA-2obvA: 15.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OBV_A_SAMA501_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.01A	2obvA-2obvA: 69.1	2obvA-2obvA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P02_A_SAMA2_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.23A	2p02A-2obvA: 65.0	2p02A-2obvA: 85.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEO_A_LNRA200_1 (D7R4 PROTEIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 12	ARG A 84 ILE A 37 VAL A 65 PHE A 99 ASP A 100	None	1.20A	2qeoA-2obvA: undetectable	2qeoA-2obvA: 18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YZQ_A_SAMA6075_0 (PUTATIVE UNCHARACTERIZED PROTEIN PH1780)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 12	VAL A 83 ILE A 87 ILE A 90 GLU A 27 GLN A 36	None	1.31A	2yzqA-2obvA: undetectable	2yzqA-2obvA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HJO_B_EAAB211_1 (GLUTATHIONE S-TRANSFERASE P)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 8	TRP A 300 ILE A 332 VAL A 314 GLY A 140	None	0.51A	3hjoB-2obvA: undetectable	3hjoB-2obvA: 21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKA_A_SAMA400_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE H)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 12	THR A 288 GLY A 133 GLY A 323 ARG A 292 ASP A 291	None	1.41A	3tkaA-2obvA: undetectable	3tkaA-2obvA: 23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_B_W9TB513_1 (HEMOLYTIC LECTIN CEL-III)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 6	CYH A 34 THR A 262 CYH A 60 ILE A 87	None	1.30A	3w9tB-2obvA: undetectable	3w9tB-2obvA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 5	LYS A 234 ILE A 196 VAL A 186 LEU A 156	None	1.08A	3wzdA-2obvA: undetectable	3wzdA-2obvA: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BVA_A_T3A1314_1 (THIOMORPHOLINE-CARBO XYLATE DEHYDROGENASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 12	VAL A 361 GLY A 358 VAL A 130 HIS A 122 PRO A 50	None	1.31A	4bvaA-2obvA: undetectable	4bvaA-2obvA: 23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HOJ_A_ACTA303_0 (REGF PROTEIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 5	VAL A 226 ARG A 163 MET A 164 LEU A 173	None	1.47A	4hojA-2obvA: undetectable	4hojA-2obvA: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_C_SVRC301_1 (NUCLEOCAPSID PROTEIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 8	GLY A 63 ASN A 105 PRO A 255 ILE A 87	None	1.01A	4j4vC-2obvA: 0.6	4j4vC-2obvA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0B_B_SAMB504_1 (S-ADENOSYLMETHIONINE SYNTHASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-3.6A)	0.32A	4k0bB-2obvA: 27.0	4k0bB-2obvA: 22.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.23A	4kttA-2obvA: 57.0	4kttA-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_A_SAMA405_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.36A	4kttB-2obvA: 63.0	4kttB-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.19A	4kttC-2obvA: 56.7	4kttC-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.16A	4kttD-2obvA: 63.4	4kttD-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_A_ADNA403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 12	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.57A	4ktvA-2obvA: 56.4 4ktvB-2obvA: 62.1	4ktvA-2obvA: 85.68 4ktvB-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_C_ADNC403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 11	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.35A	4ktvC-2obvA: 55.9 4ktvD-2obvA: 62.1	4ktvC-2obvA: 85.68 4ktvD-2obvA: 85.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L7I_B_SAMB501_1 (S-ADENOSYLMETHIONINE SYNTHASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	5 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-3.6A)	0.32A	4l7iB-2obvA: 26.5	4l7iB-2obvA: 22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MK4_A_CHDA504_0 (FERROCHELATASE, MITOCHONDRIAL)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 8	VAL A 359 ARG A 362 VAL A 324 GLY A 323	None	0.86A	4mk4A-2obvA: undetectable	4mk4A-2obvA: 21.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.23A	4ndnA-2obvA: 57.3	4ndnA-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.32A	4ndnB-2obvA: 63.3	4ndnB-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.15A	4ndnC-2obvA: 57.0	4ndnC-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.14A	4ndnD-2obvA: 63.7	4ndnD-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ODJ_A_SAMA500_0 (S-ADENOSYLMETHIONINE SYNTHASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.24A	4odjA-2obvA: 60.2	4odjA-2obvA: 55.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_2 (HISTONE DEACETYLASE 8)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	PRO A 151 MET A 150 TYR A 271	None	0.81A	4qa0B-2obvA: undetectable	4qa0B-2obvA: 21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_1 (HISTONE DEACETYLASE 8)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	PRO A 151 MET A 150 TYR A 271	None	0.79A	4qa0A-2obvA: undetectable	4qa0A-2obvA: 21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_A_SHHA404_2 (HISTONE DEACETYLASE 8)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	PRO A 151 MET A 150 TYR A 271	None	0.89A	4qa2B-2obvA: undetectable	4qa2B-2obvA: 21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCK_A_SAMA2409_1 (RNA-DIRECTED RNA POLYMERASE L)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	SER A 73 ASP A 35 ASP A 286	None	0.60A	4uckA-2obvA: undetectable	4uckA-2obvA: 22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WQ5_B_ACTB404_0 (TRNA N6-ADENOSINE THREONYLCARBAMOYLTRA NSFERASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	TYR A 242 ARG A 228 LYS A 223	None	0.75A	4wq5B-2obvA: undetectable	4wq5B-2obvA: 22.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_ADNA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.20A	5a1iA-2obvA: 64.9	5a1iA-2obvA: 85.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.19A	5a1iA-2obvA: 64.9	5a1iA-2obvA: 85.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E4D_B_BEZB203_0 (HYDROXYNITRILE LYASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 4	VAL A 230 ALA A 157 ILE A 205 THR A 182	None	1.12A	5e4dB-2obvA: undetectable	5e4dB-2obvA: 18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 6	ALA A 75 VAL A 77 TYR A 79 VAL A 54	None	1.04A	5eclA-2obvA: 1.1	5eclA-2obvA: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KQX_A_ROCA101_1 (PROTEASE E35D-SQV)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	6 / 12	ALA A 40 ASP A 43 ASP A 39 THR A 58 VAL A 65 ILE A 37	None	1.43A	5kqxA-2obvA: undetectable	5kqxA-2obvA: 14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N9X_A_THRA601_0 (ADENYLATION DOMAIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 7	PHE A 250 GLY A 254 GLY A 28 HIS A 29	SAM A 501 (-3.4A) None None SAM A 501 (-3.6A)	1.02A	5n9xA-2obvA: undetectable	5n9xA-2obvA: 22.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_0 (S-ADENOSYLMETHIONINE SYNTHASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	ALA A 55 GLU A 70 GLN A 113 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.21A	5t8sA-2obvA: 57.4	5t8sA-2obvA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_1 (S-ADENOSYLMETHIONINE SYNTHASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.21A	5t8sB-2obvA: 55.3	5t8sB-2obvA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_A_ACTA312_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	ILE A 200 VAL A 186 PRO A 197	None	0.55A	5uunA-2obvA: undetectable	5uunA-2obvA: 22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AG0_C_ACRC607_0 (ALPHA-AMYLASE)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 6	GLY A 91 ASP A 100 GLY A 28 GLY A 254	None	0.76A	6ag0C-2obvA: undetectable	6ag0C-2obvA: 11.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 7	ALA A 55 GLU A 70 ASP A 116 ILE A 117 ASP A 134 LYS A 289 ILE A 322	None	0.35A	6fbnA-2obvA: 60.8	6fbnA-2obvA: 85.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.26A	6fbnB-2obvA: 54.9	6fbnB-2obvA: 85.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.19A	6fboA-2obvA: 65.0	6fboA-2obvA: 82.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBP_B_ADNB404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 12	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.24A	6fbpA-2obvA: 63.6 6fbpB-2obvA: 57.3	6fbpA-2obvA: 82.61 6fbpB-2obvA: 82.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.24A	6fcbA-2obvA: 64.1	6fcbA-2obvA: 85.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCD_A_ADNA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	8 / 8	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 206 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 ( 3.7A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.17A	6fcdA-2obvA: 64.6	6fcdA-2obvA: 82.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA821_0 (GEPHYRIN)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	3 / 3	ARG A 382 PHE A 380 GLY A 378	None	0.78A	6fgdA-2obvA: undetectable	6fgdA-2obvA: 24.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6G6R_A_SAMA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	7 / 7	HIS A 29 PRO A 30 ASP A 179 LYS A 181 SER A 247 PHE A 250 ASP A 258	SAM A 501 (-3.6A) SAM A 501 (-4.2A) SAM A 501 (-2.7A) SAM A 501 (-3.9A) SAM A 501 (-2.8A) SAM A 501 (-3.4A) SAM A 501 (-3.6A)	0.20A	6g6rA-2obvA: 65.1	6g6rA-2obvA: 85.68

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EKJ_F_ACTF3008_0","BETA-CARBONIC ANHYDRASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"PHE A 282;ASP A 291;GLY A 279;GLY A 278","None","0.90A","1ekjE-2obvA:undetectable;1ekjF-2obvA:undetectable","1ekjE-2obvA:19.95;1ekjF-2obvA:19.95"],["1FB7_A_ROCA100_1","HIV-1 PROTEASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"GLY A 260;ASP A  35;GLY A  28;THR A  86;VAL A  83","None","0.94A","1fb7A-2obvA:undetectable","1fb7A-2obvA:15.36"],["1OHR_A_1UNA201_1","ASPARTYLPROTEASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",6,"ASP A  31;ASP A  35;GLY A  28;THR A  86;VAL A  83;ILE A  37","None","1.24A","1ohrA-2obvA:undetectable","1ohrA-2obvA:15.45"],["1P7L_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.31A","1p7lC-2obvA:57.3","1p7lC-2obvA:56.74"],["1P7L_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.42A","1p7lD-2obvA:57.2","1p7lD-2obvA:56.74"],["1P7L_C_SAMC885_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.43A","1p7lC-2obvA:57.3","1p7lC-2obvA:56.74"],["1P7L_C_SAMC885_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.30A","1p7lD-2obvA:57.2","1p7lD-2obvA:56.74"],["1RG9_A_SAMA385_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.30A","1rg9A-2obvA:57.4","1rg9A-2obvA:56.74"],["1RG9_A_SAMA385_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.44A","1rg9B-2obvA:57.4","1rg9B-2obvA:56.74"],["1RG9_B_SAMB485_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.42A","1rg9A-2obvA:57.4","1rg9A-2obvA:56.74"],["1RG9_B_SAMB485_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.30A","1rg9B-2obvA:57.4","1rg9B-2obvA:56.74"],["1RG9_C_SAMC585_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.33A","1rg9C-2obvA:57.3","1rg9C-2obvA:56.74"],["1RG9_C_SAMC585_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.41A","1rg9D-2obvA:57.3","1rg9D-2obvA:56.74"],["1RG9_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.42A","1rg9C-2obvA:57.3","1rg9C-2obvA:56.74"],["1RG9_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.32A","1rg9D-2obvA:57.3","1rg9D-2obvA:56.74"],["2NNP_A_ROCA401_1","PROTEASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"GLY A 260;ASP A  35;GLY A  28;THR A  86;VAL A  83","None","0.94A","2nnpA-2obvA:undetectable","2nnpA-2obvA:15.45"],["2OBV_A_SAMA501_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.01A","2obvA-2obvA:69.1","2obvA-2obvA:100.00"],["2P02_A_SAMA2_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.23A","2p02A-2obvA:65.0","2p02A-2obvA:85.68"],["2QEO_A_LNRA200_1","D7R4 PROTEIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"ARG A  84;ILE A  37;VAL A  65;PHE A  99;ASP A 100","None","1.20A","2qeoA-2obvA:undetectable","2qeoA-2obvA:18.78"],["2YZQ_A_SAMA6075_0","PUTATIVE UNCHARACTERIZED PROTEIN PH1780","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"VAL A  83;ILE A  87;ILE A  90;GLU A  27;GLN A  36","None","1.31A","2yzqA-2obvA:undetectable","2yzqA-2obvA:21.87"],["3HJO_B_EAAB211_1","GLUTATHIONE S-TRANSFERASE P","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"TRP A 300;ILE A 332;VAL A 314;GLY A 140","None","0.51A","3hjoB-2obvA:undetectable","3hjoB-2obvA:21.09"],["3TKA_A_SAMA400_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE H","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"THR A 288;GLY A 133;GLY A 323;ARG A 292;ASP A 291","None","1.41A","3tkaA-2obvA:undetectable","3tkaA-2obvA:23.43"],["3W9T_B_W9TB513_1","HEMOLYTIC LECTIN CEL-III","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"CYH A  34;THR A 262;CYH A  60;ILE A  87","None","1.30A","3w9tB-2obvA:undetectable","3w9tB-2obvA:21.54"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"LYS A 234;ILE A 196;VAL A 186;LEU A 156","None","1.08A","3wzdA-2obvA:undetectable","3wzdA-2obvA:21.71"],["4BVA_A_T3A1314_1","THIOMORPHOLINE-CARBOXYLATE DEHYDROGENASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"VAL A 361;GLY A 358;VAL A 130;HIS A 122;PRO A  50","None","1.31A","4bvaA-2obvA:undetectable","4bvaA-2obvA:23.84"],["4HOJ_A_ACTA303_0","REGF PROTEIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"VAL A 226;ARG A 163;MET A 164;LEU A 173","None","1.47A","4hojA-2obvA:undetectable","4hojA-2obvA:21.03"],["4J4V_C_SVRC301_1","NUCLEOCAPSID PROTEIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"GLY A  63;ASN A 105;PRO A 255;ILE A  87","None","1.01A","4j4vC-2obvA:0.6","4j4vC-2obvA:21.88"],["4K0B_B_SAMB504_1","S-ADENOSYLMETHIONINE SYNTHASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-3.6A)","0.32A","4k0bB-2obvA:27.0","4k0bB-2obvA:22.42"],["4KTT_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.23A","4kttA-2obvA:57.0","4kttA-2obvA:85.68"],["4KTT_A_SAMA405_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.36A","4kttB-2obvA:63.0","4kttB-2obvA:85.68"],["4KTT_C_SAMC404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.19A","4kttC-2obvA:56.7","4kttC-2obvA:85.68"],["4KTT_C_SAMC404_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.16A","4kttD-2obvA:63.4","4kttD-2obvA:85.68"],["4KTV_A_ADNA403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.57A","4ktvA-2obvA:56.4;4ktvB-2obvA:62.1","4ktvA-2obvA:85.68;4ktvB-2obvA:85.68"],["4KTV_C_ADNC403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.35A","4ktvC-2obvA:55.9;4ktvD-2obvA:62.1","4ktvC-2obvA:85.68;4ktvD-2obvA:85.68"],["4L7I_B_SAMB501_1","S-ADENOSYLMETHIONINE SYNTHASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",5,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-3.6A)","0.32A","4l7iB-2obvA:26.5","4l7iB-2obvA:22.42"],["4MK4_A_CHDA504_0","FERROCHELATASE, MITOCHONDRIAL","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"VAL A 359;ARG A 362;VAL A 324;GLY A 323","None","0.86A","4mk4A-2obvA:undetectable","4mk4A-2obvA:21.26"],["4NDN_A_SAMA407_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.23A","4ndnA-2obvA:57.3","4ndnA-2obvA:85.68"],["4NDN_A_SAMA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.32A","4ndnB-2obvA:63.3","4ndnB-2obvA:85.68"],["4NDN_C_SAMC405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.15A","4ndnC-2obvA:57.0","4ndnC-2obvA:85.68"],["4NDN_C_SAMC405_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.14A","4ndnD-2obvA:63.7","4ndnD-2obvA:85.68"],["4ODJ_A_SAMA500_0","S-ADENOSYLMETHIONINE SYNTHASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.24A","4odjA-2obvA:60.2","4odjA-2obvA:55.90"],["4QA0_A_SHHA404_2","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"PRO A 151;MET A 150;TYR A 271","None","0.81A","4qa0B-2obvA:undetectable","4qa0B-2obvA:21.81"],["4QA0_B_SHHB404_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"PRO A 151;MET A 150;TYR A 271","None","0.79A","4qa0A-2obvA:undetectable","4qa0A-2obvA:21.81"],["4QA2_A_SHHA404_2","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"PRO A 151;MET A 150;TYR A 271","None","0.89A","4qa2B-2obvA:undetectable","4qa2B-2obvA:21.81"],["4UCK_A_SAMA2409_1","RNA-DIRECTED RNA POLYMERASE L","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"SER A  73;ASP A  35;ASP A 286","None","0.60A","4uckA-2obvA:undetectable","4uckA-2obvA:22.25"],["4WQ5_B_ACTB404_0","TRNA N6-ADENOSINE THREONYLCARBAMOYLTRANSFERASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"TYR A 242;ARG A 228;LYS A 223","None","0.75A","4wq5B-2obvA:undetectable","4wq5B-2obvA:22.54"],["5A1I_A_ADNA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.20A","5a1iA-2obvA:64.9","5a1iA-2obvA:85.68"],["5A1I_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.19A","5a1iA-2obvA:64.9","5a1iA-2obvA:85.68"],["5E4D_B_BEZB203_0","HYDROXYNITRILE LYASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"VAL A 230;ALA A 157;ILE A 205;THR A 182","None","1.12A","5e4dB-2obvA:undetectable","5e4dB-2obvA:18.06"],["5ECL_A_ILEA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"ALA A  75;VAL A  77;TYR A  79;VAL A  54","None","1.04A","5eclA-2obvA:1.1","5eclA-2obvA:20.14"],["5KQX_A_ROCA101_1","PROTEASE E35D-SQV","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",6,"ALA A  40;ASP A  43;ASP A  39;THR A  58;VAL A  65;ILE A  37","None","1.43A","5kqxA-2obvA:undetectable","5kqxA-2obvA:14.75"],["5N9X_A_THRA601_0","ADENYLATION DOMAIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"PHE A 250;GLY A 254;GLY A  28;HIS A  29","SAM A 501 (-3.4A);None;None;SAM A 501 (-3.6A)","1.02A","5n9xA-2obvA:undetectable","5n9xA-2obvA:22.67"],["5T8S_B_SAMB402_0","S-ADENOSYLMETHIONINE SYNTHASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"ALA A  55;GLU A  70;GLN A 113;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.21A","5t8sA-2obvA:57.4","5t8sA-2obvA:56.28"],["5T8S_B_SAMB402_1","S-ADENOSYLMETHIONINE SYNTHASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.21A","5t8sB-2obvA:55.3","5t8sB-2obvA:56.28"],["5UUN_A_ACTA312_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"ILE A 200;VAL A 186;PRO A 197","None","0.55A","5uunA-2obvA:undetectable","5uunA-2obvA:22.64"],["6AG0_C_ACRC607_0","ALPHA-AMYLASE","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",4,"GLY A  91;ASP A 100;GLY A  28;GLY A 254","None","0.76A","6ag0C-2obvA:undetectable","6ag0C-2obvA:11.65"],["6FBN_B_SAMB401_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"ALA A  55;GLU A  70;ASP A 116;ILE A 117;ASP A 134;LYS A 289;ILE A 322","None","0.35A","6fbnA-2obvA:60.8","6fbnA-2obvA:85.42"],["6FBN_B_SAMB401_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.26A","6fbnB-2obvA:54.9","6fbnB-2obvA:85.42"],["6FBO_A_ADNA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.19A","6fboA-2obvA:65.0","6fboA-2obvA:82.61"],["6FBP_B_ADNB404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.24A","6fbpA-2obvA:63.6;6fbpB-2obvA:57.3","6fbpA-2obvA:82.61;6fbpB-2obvA:82.61"],["6FCB_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.24A","6fcbA-2obvA:64.1","6fcbA-2obvA:85.42"],["6FCD_A_ADNA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",8,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 206;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 ( 3.7A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.17A","6fcdA-2obvA:64.6","6fcdA-2obvA:82.61"],["6FGD_A_ACTA821_0","GEPHYRIN","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",3,"ARG A 382;PHE A 380;GLY A 378","None","0.78A","6fgdA-2obvA:undetectable","6fgdA-2obvA:24.41"],["6G6R_A_SAMA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","2obv","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","Homo sapiens",7,"HIS A  29;PRO A  30;ASP A 179;LYS A 181;SER A 247;PHE A 250;ASP A 258","SAM A 501 (-3.6A);SAM A 501 (-4.2A);SAM A 501 (-2.7A);SAM A 501 (-3.9A);SAM A 501 (-2.8A);SAM A 501 (-3.4A);SAM A 501 (-3.6A)","0.20A","6g6rA-2obvA:65.1","6g6rA-2obvA:85.68"]]